Schizophrenia

When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

最后审阅: 23 Sep 2025
最后更新: 21 Mar 2025

小结

定义

病史和体格检查

关键诊断因素

  • auditory hallucinations
  • delusions
  • avolition
  • anhedonia
  • asocial behavior
  • affective blunting
  • alogia
  • cognitive deficits
  • somatization
完整详情

其他诊断因素

  • lack of insight (anosognosia)
  • bizarre or disorganized behavior
  • tangentiality and looseness of association (derailment)
  • circumstantiality
  • pressured speech
  • distractible speech
  • depression
  • suicidality
  • anxiety
  • elation
  • incongruent affect
  • verbigeration
  • perseveration
  • word salad
  • derealization
  • nonauditory hallucinations
  • déjà-vu
  • stilted goal-directed behaviors
  • catatonic symptoms
  • "soft" neurologic deficits
完整详情

危险因素

  • family history of schizophrenia
  • increasing paternal age
  • obstetric complications
  • cannabis use
  • low IQ
  • motor dysfunction
  • psychological stress
  • childhood abuse
  • migrant status
完整详情

诊断性检查

首要检查

  • clinical diagnosis
完整详情

需考虑的检查

  • MRI/CT head
  • serum HIV enzyme-linked immunosorbent assay
  • serum rapid plasma reagin (RPR) test
  • CBC including absolute neutrophil count (ANC)
  • drug toxicology screen
  • BUN and electrolytes
  • liver function tests
  • thyroid-stimulating hormone
  • pregnancy test
  • genetic testing
完整详情

治疗流程

初步治疗

at risk of developing psychosis

急症处理

acute psychotic episode

持续性治疗

chronic symptoms

treatment-resistant schizophrenia

撰稿人

专家顾问

Xiaoduo Fan, MD, MPH, MSc

Professor of Psychiatry

Director, UMass MIND

UMass Memorial Health/UMass Chan Medical School

Worcester

MA

利益声明

XF has received research support from Otsuka, Roche, Intra-Cellular Therapies, Avanir, and Janssen. XF holds a patent on "combination treatment for neuropsychiatric disorders" (USPTO patent # 11,331,319).

鸣谢

Dr Xiaoduo Fan would like to gratefully acknowledge Dr Adrian Preda and Dr Robert G. Bota, previous contributors to this topic.

利益声明

AP and RGB declare that they have no competing interests.

同行评议者

David Taylor, PhD

Chief Pharmacist

South London and Maudsley NHS Foundation Trust

London

UK

利益声明

DT declares that he has no competing interests.

Joel Yager, MD

Professor

Department of Psychiatry

University of New Mexico School of Medicine

Albuquerque

NM

Раскрытие информации

JY declares that he has no competing interests.

Kemal Sagduyu, MD

Professor of Psychiatry

University of Missouri Kansas City

Kansas City

MO

Раскрытие информации

KS declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Список литературы

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Основные статьи

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.Полный текст

American Psychiatric Association. ​The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia. Washington, DC: American Psychiatric Association; 2021.Полный текст

Hasan A, Falkai P, Wobrock T, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry. 2012 Jul;13(5):318-78. Аннотация

Статьи, указанные как источники

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Использование этого контента попадает под действие нашего заявления об отказе от ответственности